Histiocytosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Histiocytosis}} {{CMG}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. ==Overview== ==..." |
|||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
==Medical Therapy== | ==Medical Therapy== | ||
===Pharmacotherapy=== | |||
*Chemotherapy | *Chemotherapy | ||
**[[Cladribine]] or [[2CDA]] or [[leustatin]] | **[[Cladribine]] or [[2CDA]] or [[leustatin]] | ||
**[[Etoposide]] | **[[Etoposide]] | ||
**[[Vinblastine]] or [[Velban]] | **[[Vinblastine]] or [[Velban]] | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Latest revision as of 15:50, 21 September 2012
Histiocytosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Histiocytosis medical therapy On the Web |
American Roentgen Ray Society Images of Histiocytosis medical therapy |
Risk calculators and risk factors for Histiocytosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Medical Therapy
Pharmacotherapy
- Chemotherapy
- Cladribine or 2CDA or leustatin
- Etoposide
- Vinblastine or Velban